Collaboration, data, and digital innovation are crucial to supporting the future of cell and gene therapy manufacturing. We are delighted to share key highlights from a recent roundtable discussion with CGT thought leaders, including CEO & Co-founder Alexander Seyf, as featured in Discover Pharma’s insightful article.

Key highlights include:
Breaking down data silos
The potential of standardization
Accelerating early digital and AI adoption
Trust as the bedrock of effective data collaboration

At Autolomous, we’re committed to driving digital transformation, streamlining manufacturing processes, and expanding access to life-changing cell and gene therapies.

Read the full article here.